IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV12I9A89

Acquired coronary artery aneurysm following treatment with bioresorbable vascular scaffolds

Kevin O’Gallagher*, BA (Hons), MBBS, MRCP; Roberto Nerla, PhD; Jonathan Hill, MA, MBChb, FRCP; Jonathan Byrne, MBChB, PhD, FRCP

A 41-year-old female underwent deployment of two bioresorbable vascular scaffolds (BVS) (3.5×28 mm, 3.5×18 mm) (Abbott Vascular, Santa Clara, CA, USA) to a long segment of disease in the right coronary artery (RCA) as a staged intervention to bystander disease following a myocardial infarction. Due to a significant waist post deployment, post-dilation with 3.5×20 mm Pantera (Biotronik, Berlin, Germany) and 3.5×12 mm Quantum Apex™ (Boston Scientific, Marlborough, MA, USA) non-compliant balloons to 18 atm was required.

She re-presented with angina 21 months later. Angiography revealed a significant ostial RCA stenosis, with a localised coronary artery aneurysm within the scaffolded segment (Panel A). Pressure wire assessment yielded an FFR of 0.76 with a step at the ostium. Optical coherence tomography confirmed a large, acquired aneurysm at the point of minimal scaffold overlap (Panel B, Panel C). No malapposition was observed, and the scaffold appeared to have expanded with the vessel far beyond normal scaffold dimensions. A short drug-eluting stent (DES) was deployed to the ostium. The aneurysmal segment was managed conservatively with dual antiplatelet therapy (aspirin and clopidogrel).

This extreme form of positive remodelling in a BVS has not, to our knowledge, been described previously. The mechanism of acquired aneurysm following DES/BVS deployment remains unclear; however, hypersensitivity to the drug and/or polymer is possible. In this case, it is possible that “double-dose” everolimus at the point of BVS overlap may have been a factor in aneurysm formation.

Conflict of interest statement

J. Hill has received consulting fees from Abbott and St. Jude Medical. The other authors have no conflicts of interest to declare.

Volume 12 Number 9
Oct 20, 2016
Volume 12 Number 9
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV12I1A10 May 16, 2016
Coronary aneurysm without malapposition after bioresorbable vascular scaffold implantation
Timmers L et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV11I1A14 May 19, 2015
Very late bioresorbable vascular scaffold thrombosis: a new clinical entity
Azzalini L et al
free
Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.45

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved